StockNews.com started coverage on shares of Ayala Pharmaceuticals (NASDAQ:ADXS – Get Free Report) in a research note issued on Tuesday. The firm set a “sell” rating on the stock.
Ayala Pharmaceuticals Stock Up 125.1 %
Shares of NASDAQ:ADXS opened at $0.11 on Tuesday. The firm has a 50 day moving average of $0.03 and a 200 day moving average of $0.27. The company has a market capitalization of $4.48 million, a price-to-earnings ratio of -0.01 and a beta of 1.51. Ayala Pharmaceuticals has a 52 week low of $0.00 and a 52 week high of $1.49.
About Ayala Pharmaceuticals
See Also
- Five stocks we like better than Ayala Pharmaceuticals
- Most active stocks: Dollar volume vs share volume
- TJX Stock: A Buying Opportunity Before the Holiday Rush
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- Micron’s Blowout Results Pave the Way for Seagate’s Stock Surge
- Health Care Stocks Explained: Why You Might Want to Invest
- Zeta Global’s AI Cloud: Your Secret Weapon for Massive Growth
Receive News & Ratings for Ayala Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ayala Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.